- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccines against Coronaviruses: The State of the Art
Authors
Keywords
-
Journal
Vaccines
Volume 8, Issue 2, Pages 309
Publisher
MDPI AG
Online
2020-06-18
DOI
10.3390/vaccines8020309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent insights into 2019-nCoV: a brief but comprehensive review
- (2020) Qingmei Han et al. JOURNAL OF INFECTION
- Potential interventions for novel coronavirus in China: A systematic review
- (2020) Lei Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV
- (2020) Vargab Baruah et al. JOURNAL OF MEDICAL VIROLOGY
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness
- (2020) Robyn Ralph et al. Journal of Infection in Developing Countries
- Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
- (2020) Ning Wang et al. Frontiers in Microbiology
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
- (2020) Junxiong Pang et al. Journal of Clinical Medicine
- Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
- (2020) Balamurugan Shanmugaraj et al. Pathogens
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
- (2019) Danielle Adney et al. Viruses-Basel
- A highly immunogenic, protective and safe adenovirus-based vaccine expressing MERS-CoV S1-CD40L fusion protein in transgenic human DPP4 mouse model
- (2019) Anwar M Hashem et al. JOURNAL OF INFECTIOUS DISEASES
- Broad-spectrum coronavirus antiviral drug discovery
- (2019) Allison L. Totura et al. Expert Opinion on Drug Discovery
- Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
- (2019) Kayvon Modjarrad et al. LANCET INFECTIOUS DISEASES
- Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
- (2019) Chean Yeah Yong et al. Frontiers in Microbiology
- A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization
- (2018) Renqiang Liu et al. ANTIVIRAL RESEARCH
- Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
- (2018) Mun Peak Nyon et al. VACCINE
- Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
- (2018) Seo-Yeon Jung et al. VACCINE
- Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model
- (2018) Bianca S. Bodmer et al. VIROLOGY
- Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
- (2018) Yao Deng et al. Emerging Microbes & Infections
- CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice
- (2018) Svenja Veit et al. Viruses-Basel
- Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus
- (2018) Jiaming Lan et al. VIROLOGICA SINICA
- ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
- (2017) Naif Khalaf Alharbi et al. VACCINE
- MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
- (2017) Christopher M. Coleman et al. VACCINE
- DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice
- (2017) Hang Chi et al. VACCINE
- Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
- (2017) Yufei Wang et al. Human Vaccines & Immunotherapeutics
- Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis
- (2017) Vineet D. Menachery et al. mSphere
- Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
- (2017) Vincent J. Munster et al. npj Vaccines
- Airway Memory CD4 + T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
- (2016) Jincun Zhao et al. IMMUNITY
- Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus–Derived CD8+T Cell Epitopes and Host MHC
- (2016) William J. Liu et al. JOURNAL OF IMMUNOLOGY
- One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
- (2016) Christoph Wirblich et al. JOURNAL OF VIROLOGY
- Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
- (2016) Oi-Wing Ng et al. VACCINE
- MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques
- (2016) Chong Wang et al. Oncotarget
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Merging W W and W W + jet with Minlo
- (2016) Keith Hamilton et al. JOURNAL OF HIGH ENERGY PHYSICS
- Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
- (2016) Qidi Wang et al. ACS Infectious Diseases
- Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
- (2015) Xiaojuan Guo et al. IMMUNOLOGY
- A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
- (2015) Anna H. Malczyk et al. JOURNAL OF VIROLOGY
- Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates
- (2015) Jose A. Regla-Nava et al. JOURNAL OF VIROLOGY
- Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
- (2015) Asisa Volz et al. JOURNAL OF VIROLOGY
- A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
- (2015) Karuppiah Muthumani et al. Science Translational Medicine
- Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge
- (2015) Jiaming Lan et al. EBioMedicine
- Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
- (2014) Yoshikazu Honda-Okubo et al. JOURNAL OF VIROLOGY
- Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
- (2014) Jiaming Lan et al. PLoS One
- Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
- (2014) Eun Kim et al. VACCINE
- Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design
- (2014) Cuiqing Ma et al. VACCINE
- Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
- (2014) Cuiqing Ma et al. VACCINE
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein
- (2013) C. Fett et al. JOURNAL OF VIROLOGY
- The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
- (2013) H. Mou et al. JOURNAL OF VIROLOGY
- Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
- (2013) L. Du et al. JOURNAL OF VIROLOGY
- A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
- (2013) Lanying Du et al. PLoS One
- Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
- (2013) F. Almazan et al. mBio
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
- (2012) Byoung-Shik Shim et al. Virology Journal
- Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
- (2011) F. Tang et al. JOURNAL OF IMMUNOLOGY
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
- (2010) J. Zhao et al. JOURNAL OF VIROLOGY
- Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection
- (2009) Yan-Ying Fan et al. ARCHIVES OF VIROLOGY
- SARS vaccines: where are we?
- (2009) Rachel L Roper et al. Expert Review of Vaccines
- Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
- (2008) R. H. See et al. JOURNAL OF GENERAL VIROLOGY
- Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
- (2008) Lanying Du et al. VACCINE
- A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
- (2008) Julie E. Martin et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started